ConductScience.org, home

Paper37726283

mRNA vaccines in disease prevention and treatment.

Zhang G and 4 others. Signal Transduct Target Ther, 2023. Cited by 202 papers, by iCite.

Cite this record

ConductScience Library. mRNA vaccines in disease prevention and treatment. Papers, record 37726283. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37726283

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
mRNA vaccines in disease prevention and treatment.
PubMed
Journal
Signal Transduct Target Ther
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
202
iCite
Relative citation ratio, by iCite
19.3
iCite
Revised in PubMed
2023-11-23
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang GGang
2Tang TTianyu
3Chen YYinfeng
4Huang XXinghttps://orcid.org/0000-0002-8886-2777
5Liang TTingbohttps://orcid.org/0000-0003-0143-3353

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
COVID-19Major topic
Humans
Prospective Studies
Retrospective Studies
Adjuvants, Immunologic
mRNA Vaccines

References254

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134794169Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine.Nature2022https://conductscience.org/library/papers/34794169PubMed
232728218An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.Nature2020https://conductscience.org/library/papers/32728218PubMed
332591862
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases.
Cancer Immunol Immunother2020https://conductscience.org/library/papers/32591862PubMed
416947019T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells.Cancer Immunol Immunother2007https://conductscience.org/library/papers/16947019PubMed
530518847Structural and molecular mechanisms for the control of eukaryotic 5'-3' mRNA decay.Nat Struct Mol Biol2018https://conductscience.org/library/papers/30518847PubMed
629456015Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity.Vaccine2018https://conductscience.org/library/papers/29456015PubMed
733685460Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development.Mol Cancer2021https://conductscience.org/library/papers/33685460PubMed
88760800Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.J Exp Med1996https://conductscience.org/library/papers/8760800PubMed
932153780Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial.Clin Transl Immunology2020https://conductscience.org/library/papers/32153780PubMed
1023921513A novel, disruptive vaccination technology: self-adjuvanted RNActive(®) vaccines.Hum Vaccin Immunother2013https://conductscience.org/library/papers/23921513PubMed
1125263094The ReNAissanCe of mRNA-based cancer therapy.Expert Rev Vaccines2015https://conductscience.org/library/papers/25263094PubMed
1229567706Personalized vaccines for cancer immunotherapy.Science2018https://conductscience.org/library/papers/29567706PubMed
1335339668Recent advances of nanodrug delivery system in the treatment of hematologic malignancies.Semin Cancer Biol2022https://conductscience.org/library/papers/35339668PubMed
1430803823mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.Mol Ther2019https://conductscience.org/library/papers/30803823PubMed
1526321183mRNA: Fulfilling the Promise of Gene Therapy.Mol Ther2015https://conductscience.org/library/papers/26321183PubMed
1630504800Modified VEGF-A mRNA induces sustained multifaceted microvascular response and accelerates diabetic wound healing.Sci Rep2018https://conductscience.org/library/papers/30504800PubMed
1718797453Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.Mol Ther2008https://conductscience.org/library/papers/18797453PubMed
1828527533Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015.J Am Coll Cardiol2017https://conductscience.org/library/papers/28527533PubMed
1935264324Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.BMJ2022https://conductscience.org/library/papers/35264324PubMed
208903508The eIF-2alpha kinases and the control of protein synthesis.FASEB J1996https://conductscience.org/library/papers/8903508PubMed

See all 254 referencesDownload CSV of references

Cited by141

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 202 citations.

PMIDTitleJournalYearIn PapersSource
42958362Neoantigen nanovaccines for cancer immunotherapy: design strategies, translational bottlenecks, and clinical prospects.J Nanobiotechnology2026https://conductscience.org/library/papers/42958362PubMed
42866351Exploring the potential of mRNA vaccines in combatting communicable and non-communicable diseases in low-income and lower-middle-income countries.Ann Med Surg (Lond)2026https://conductscience.org/library/papers/42866351PubMed
42804114mRNA lipid nanoparticle vaccines: current status, challenges and future prospects.Mol Biomed2026https://conductscience.org/library/papers/42804114PubMed
42618806Enhanced antitumor immunity of mRNA vaccines by bioorthogonal-like delayed activation of exogeneous STING.Nat Biotechnol2026https://conductscience.org/library/papers/42618806PubMed
42614300From pathogen defence to precision health infrastructure: mRNA vaccines beyond infectious disease in preventive health, chronic disease management, and population wellbeing.Front Bioeng Biotechnol2026https://conductscience.org/library/papers/42614300PubMed
42605164Immunological Evaluation of mRNA-LNP Vaccines Targeting Conserved S2 and NSP3 Domains of SARS-CoV-2.Biotechnol J2026https://conductscience.org/library/papers/42605164PubMed
42599953Design of an immunogen containing multidimensionally conserved and immunogenic parts of the HIV proteome.PLoS Comput Biol2026https://conductscience.org/library/papers/42599953PubMed
42565117Beyond the genetic code: orchestrating epigenetic and immune landscapes with multivalent mRNA-exosome vaccines.Precis Clin Med2026https://conductscience.org/library/papers/42565117PubMed
42523811Targeting dengue through mucosal vaccination: the potential of NS1 and bacterial spore-based delivery platforms.Front Immunol2026https://conductscience.org/library/papers/42523811PubMed
42482120RNARL: reinforcement learning-driven unified generative framework for multi-objective RNA codon design.Genome Biol2026https://conductscience.org/library/papers/42482120PubMed
42472832RNA modifications in cancer: regulators of tumor evolution and therapeutic response.Mol Cancer2026https://conductscience.org/library/papers/42472832PubMed
42424000Immunotherapeutic modalities for combating multidrug-resistant bacteria: therapeutic promises of antibodies and next-generation vaccines.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42424000PubMed
42350438Next-generation mRNA vaccines: strategies to overcome stability challenges.NPJ Vaccines2026https://conductscience.org/library/papers/42350438PubMed
42342874Immunological mechanisms of mRNA vaccines for infectious diseases.Nature2026https://conductscience.org/library/papers/42342874PubMed
42199419Emerging frontiers in glioma therapy: the evolving role of glioma vaccines.Front Immunol2026https://conductscience.org/library/papers/42199419PubMed
42188740Nucleoside Modifications and Poly(A) Tail Length Greatly Influence Protein Expression from In Vitro-Transcribed mRNA in a Salmonid Cell Line.Vaccines (Basel)2026https://conductscience.org/library/papers/42188740PubMed
42140901A nanobody-based proteolysis-targeting chimera offers broad-spectrum protection against diverse influenza virus infections.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42140901PubMed
42123607Sulforaphane-Activated Functional Nucleic Acids for Cancer Therapy: Mechanisms, Delivery Strategies, and Nanomedicine Advances.Int J Mol Sci2026https://conductscience.org/library/papers/42123607PubMed
42095075Single-cell transcriptomics reveal altered B cell responses and T cell senescence in geriatric non-responders to COVID-19 mRNA vaccination.iScience2026https://conductscience.org/library/papers/42095075PubMed
42087213Personalized immunotherapy in HCC: synthesis, delivery, and clinical progress of mRNA-based vaccines.Cancer Cell Int2026https://conductscience.org/library/papers/42087213PubMed

See all 141 cited byDownload CSV of cited by

Genes88

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACE259272PubTator's text mininghttps://conductscience.org/library/genes/59272NCBI Gene
ACTN481PubTator's text mininghttps://conductscience.org/library/genes/81NCBI Gene
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174NCBI Gene
BMP2650PubTator's text mininghttps://conductscience.org/library/genes/650NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD40958PubTator's text mininghttps://conductscience.org/library/genes/958NCBI Gene
CD40LG959PubTator's text mininghttps://conductscience.org/library/genes/959NCBI Gene
CD44960PubTator's text mininghttps://conductscience.org/library/genes/960NCBI Gene
CD5921PubTator's text mininghttps://conductscience.org/library/genes/921NCBI Gene
CD70970PubTator's text mininghttps://conductscience.org/library/genes/970NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CFTR1080PubTator's text mininghttps://conductscience.org/library/genes/1080NCBI Gene
CTAG1A246100PubTator's text mininghttps://conductscience.org/library/genes/246100NCBI Gene
CTAG230848PubTator's text mininghttps://conductscience.org/library/genes/30848NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
DHX5879132PubTator's text mininghttps://conductscience.org/library/genes/79132NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene

See all 88 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37726283

GET https://conductscience.org/api/papers/v1/37726283/references?page=2